OTC Markets OTCPK - Delayed Quote
USD
Astellas Pharma Inc. (ALPMF)
15.00
+1.55
(+11.52%)
At close: October 16 at 4:00:00 PM EDT
Loading chart for ALPMF
- Previous Close
13.45 - Open
15.00 - Bid 13.00 x 50000
- Ask 15.25 x 50000
- Day's Range
15.00 - 15.00 - 52 Week Range
10.00 - 17.85 - Volume
341 - Avg. Volume
5,854 - Market Cap (intraday)
26.895B - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
11.36 - EPS (TTM)
1.32 - Earnings Date Nov 4, 2026
- Forward Dividend & Yield 0.51 (3.63%)
- Ex-Dividend Date Mar 30, 2027
- 1y Target Est
--
Recent News
View More
Performance Overview
Trailing total returns as of 10/19/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
ALPMF
17.46%
Nikkei 225 (^N225)
28.96%
1-Year Return
ALPMF
57.05%
Nikkei 225 (^N225)
36.43%
3-Year Return
ALPMF
30.04%
Nikkei 225 (^N225)
106.54%
5-Year Return
ALPMF
4.29%
Nikkei 225 (^N225)
122.20%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
As of 9/23/2026
-
Market Cap
27.14B
-
Enterprise Value
29.26B
-
Trailing P/E
14.82
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
2.02
-
Price/Book (mrq)
2.22
-
Enterprise Value/Revenue
2.15
-
Enterprise Value/EBITDA
7.87
Financial Highlights
Profitability and Income Statement
-
Profit Margin
16.05%
-
Return on Assets (ttm)
8.41%
-
Return on Equity (ttm)
21.30%
-
Revenue (ttm)
2.27T
-
Net Income Avi to Common (ttm)
364.94B
-
Diluted EPS (ttm)
1.32
Balance Sheet and Cash Flow
-
Total Cash (mrq)
244.7B
-
Total Debt/Equity (mrq)
30.34%
-
Levered Free Cash Flow (ttm)
383.56B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
